Biotransformação da diacereína por fungos e avaliação do potencial citotóxico do seu principal metabólito humano

Detalhes bibliográficos
Autor(a) principal: Ferreira, Júlia Martins Ulhôa
Data de Publicação: 2016
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Repositório Institucional da UFG
Texto Completo: http://repositorio.bc.ufg.br/tede/handle/tede/6049
Resumo: The study of biotransformation is important in the evaluation of safety and efficacy and for developing of new drug candidates. The "microbial models of mammalian metabolism", in which microbial biotransformation is used for the purpose of predict and obtaining human metabolites, is an alternative method to the use of animals for this study. Several advantages such as lower cost, a greater quantity and variety of derivatives produced, using mild conditions of reaction and decreasing the use of toxic volatile organic solvents are observed. The aim of this study was to produce derivatives of diacerein (1,8-diacetoxy-3-carboxyanthraquinone) by biotransformation using filamentous fungi and to evaluate the cytotoxicity of the main derivatives obtained given the resurgence of interest in this class of compounds. The diacerein is an anthraquinone with a wide range of biological activities, like as anti-osteoarthritis, analgesic, anti-inflammatory, antipyretic, prevention of vascular disease, insulin resistance treatment, anticancer. Analytical methodologies have been developed for monitoring the production of derivatives by thin layer chromatography and high-performance liquid chromatography (HPLC). After screening with seventeen fungal strains, Aspergillus ochraceus ATCC 1009 and Cunninghamella echinulata ATCC 9245 were selected for incubation in semipreparative scale. Of these incubations rhein (the main human metabolite) was obtained, which was characterized using the techniques Nuclear Magnetic Resonance (NMR) 1H e 13C, High Resolution Mass Spectrometry (MS), spectrometry in the UV region and analysed by HPLC. Another derivative was obtained by incubation with Aspergillus ochraceus ATCC 1009 and characterized by MS and analyzed by HPLC being, possibly, glycosylated diacerein. The influence of the addition of cytochrome P450 inhibitor in the production of metabolites was performed and inhibited the production of rhein about 41%, which may indicate the involvement of CYP1A1 and CYP1A2 in the deacetylation reaction. The cytotoxic potential of diacerein and rhein was evaluated by the tetrazolium reduction method (MTT) assay using murine fibroblast cells 3T3 and tumor cell line B16F10 (melanoma). Both the rhein, as diacerein, have demonstrated cytotoxic potential against B16F10 cells.
id UFG-2_5f2df9c47c5de1c927e99dfa6d8b28b9
oai_identifier_str oai:repositorio.bc.ufg.br:tede/6049
network_acronym_str UFG-2
network_name_str Repositório Institucional da UFG
repository_id_str
spelling Oliveira, Valéria dehttp://lattes.cnpq.br/6300240031300604Oliveira, Valéria dePaula, José Realino deKato, LucíliaOliveira, Cecília Maria Alves dehttp://lattes.cnpq.br/7137345573529858Ferreira, Júlia Martins Ulhôa2016-08-31T13:05:08Z2016-08-16FERREIRA, Júlia Martins Ulhôa. Biotransformação da diacereína por fungos e avaliação do potencial citotóxico do seu principal metabólito humano. 2016. 99 f. Dissertação (Mestrado em Ciências Farmacêuticas) - Universidade Federal de Goiás,Goiânia, 2016.http://repositorio.bc.ufg.br/tede/handle/tede/6049The study of biotransformation is important in the evaluation of safety and efficacy and for developing of new drug candidates. The "microbial models of mammalian metabolism", in which microbial biotransformation is used for the purpose of predict and obtaining human metabolites, is an alternative method to the use of animals for this study. Several advantages such as lower cost, a greater quantity and variety of derivatives produced, using mild conditions of reaction and decreasing the use of toxic volatile organic solvents are observed. The aim of this study was to produce derivatives of diacerein (1,8-diacetoxy-3-carboxyanthraquinone) by biotransformation using filamentous fungi and to evaluate the cytotoxicity of the main derivatives obtained given the resurgence of interest in this class of compounds. The diacerein is an anthraquinone with a wide range of biological activities, like as anti-osteoarthritis, analgesic, anti-inflammatory, antipyretic, prevention of vascular disease, insulin resistance treatment, anticancer. Analytical methodologies have been developed for monitoring the production of derivatives by thin layer chromatography and high-performance liquid chromatography (HPLC). After screening with seventeen fungal strains, Aspergillus ochraceus ATCC 1009 and Cunninghamella echinulata ATCC 9245 were selected for incubation in semipreparative scale. Of these incubations rhein (the main human metabolite) was obtained, which was characterized using the techniques Nuclear Magnetic Resonance (NMR) 1H e 13C, High Resolution Mass Spectrometry (MS), spectrometry in the UV region and analysed by HPLC. Another derivative was obtained by incubation with Aspergillus ochraceus ATCC 1009 and characterized by MS and analyzed by HPLC being, possibly, glycosylated diacerein. The influence of the addition of cytochrome P450 inhibitor in the production of metabolites was performed and inhibited the production of rhein about 41%, which may indicate the involvement of CYP1A1 and CYP1A2 in the deacetylation reaction. The cytotoxic potential of diacerein and rhein was evaluated by the tetrazolium reduction method (MTT) assay using murine fibroblast cells 3T3 and tumor cell line B16F10 (melanoma). Both the rhein, as diacerein, have demonstrated cytotoxic potential against B16F10 cells.O estudo da biotransformação é de fundamental importância na avaliação da segurança e eficácia e para o desenvolvimento de novos candidatos a fármacos. O “Modelo microbiano do metabolismo animal”, no qual a biotransformação microbiana é utilizada com a finalidade de prever e obter metabólitos humanos, representa um método alternativo ao uso de animais para esse estudo, uma vez que são observadas diversas vantagens como menor custo, maior quantidade e variedade de derivados produzidos, utilização de condições brandas de reação e redução da utilização de solventes orgânicos voláteis tóxicos. O objetivo deste estudo foi produzir derivados da diacereína (1,8-diacetoxi-3-carboxiantraquinona) por biotransformação, utilizando fungos filamentosos e avaliar a citotoxicidade dos principais derivados obtidos, em função do ressurgimento do interesse desta classe de compostos. A diacereína é uma antraquinona com ampla gama de atividades biológicas - antiosteoartrósica, analgésica, anti-inflamatória, antipirética, prevenção de doenças vasculares, tratamento de resistência à insulina, anticâncer. Metodologias analíticas foram desenvolvidas para o monitoramento da produção dos derivados por cromatografia em camada delgada e cromatografia líquida de alta eficiência (CLAE). Após triagem com dezessete cepas fúngicas, Aspergillus ochraceus ATCC 1009 e Cunninghamella echinulata ATCC 9245 foram selecionadas para incubações em escala semipreparativa. Dessas incubações obteve-se reína (o principal metabólito humano), a qual foi caracterizada utilizando as técnicas Ressonância Magnética Nuclear de 1H e 13C, Espectrometria de Massas de Alta Resolução (EM), Espectrometria na região do ultravioleta/visível e analisada por CLAE. Outro derivado foi obtido da incubação com Aspergillus ochraceus ATCC 1009 e caracterizado por EM e analisado em CLAE, sendo, possivelmente, a diacereína glicosilada. A influência da adição de inibidor do citocromo P450 na produção dos metabólitos foi realizada e inibiu a produção de reína em cerca de 41%, o que pode indicar o envolvimento do CYP1A1 e CYP1A2 na reação de desacetilação.O potencial citotóxico da diacereína e da reína foi avaliado pelo método de redução do tetrazólio (MTT) utilizando células de fibroblasto murino 3T3 e da linhagem tumoral B16F10 (melanoma). Tanto a reína, quanto a diacereína, demonstraram potencial citotóxico contra células B16F10.Submitted by Marlene Santos (marlene.bc.ufg@gmail.com) on 2016-08-30T17:41:02Z No. of bitstreams: 2 Dissertação - Júlia Martins Ulhôa Ferreira - 2016.pdf: 3148442 bytes, checksum: fc17d72cc71fdebb2a4ec57487e7cd21 (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5)Approved for entry into archive by Luciana Ferreira (lucgeral@gmail.com) on 2016-08-31T13:05:08Z (GMT) No. of bitstreams: 2 Dissertação - Júlia Martins Ulhôa Ferreira - 2016.pdf: 3148442 bytes, checksum: fc17d72cc71fdebb2a4ec57487e7cd21 (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5)Made available in DSpace on 2016-08-31T13:05:08Z (GMT). No. of bitstreams: 2 Dissertação - Júlia Martins Ulhôa Ferreira - 2016.pdf: 3148442 bytes, checksum: fc17d72cc71fdebb2a4ec57487e7cd21 (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) Previous issue date: 2016-08-16Conselho Nacional de Pesquisa e Desenvolvimento Científico e Tecnológico - CNPqapplication/pdfporUniversidade Federal de GoiásPrograma de Pós-graduação em Ciências Farmacêuticas (FF)UFGBrasilFaculdade Farmácia - FF (RG)http://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessBiotransformaçãoDiacereínaAspergillus ochraceusGlicosilaçãoCunninghamella echinulataCitotoxicidadeBiotransformationDiacereinglycosylationCytotoxicityCIENCIAS BIOLOGICAS::FARMACOLOGIABiotransformação da diacereína por fungos e avaliação do potencial citotóxico do seu principal metabólito humanoBiotransformation of diacerein by fungi and evaluation of the cytotoxic potential of its main human metaboliteinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesis8249369881961524126006006006006010281161524209375700814650651154363-2555911436985713659reponame:Repositório Institucional da UFGinstname:Universidade Federal de Goiás (UFG)instacron:UFGLICENSElicense.txtlicense.txttext/plain; charset=utf-82165http://repositorio.bc.ufg.br/tede/bitstreams/7218cdd2-7837-4d3c-9ca7-e81de79ffe2b/downloadbd3efa91386c1718a7f26a329fdcb468MD51CC-LICENSElicense_urllicense_urltext/plain; charset=utf-843http://repositorio.bc.ufg.br/tede/bitstreams/2fc390f4-f755-4dba-ae5f-840d63f97c1b/download321f3992dd3875151d8801b773ab32edMD52license_textlicense_texttext/html; charset=utf-80http://repositorio.bc.ufg.br/tede/bitstreams/fe4c658b-d969-4808-b229-99e734ffa50f/downloadd41d8cd98f00b204e9800998ecf8427eMD53license_rdflicense_rdfapplication/rdf+xml; charset=utf-80http://repositorio.bc.ufg.br/tede/bitstreams/2367e2be-f2c6-4cc8-99e0-9d62601f476e/downloadd41d8cd98f00b204e9800998ecf8427eMD54ORIGINALDissertação - Júlia Martins Ulhôa Ferreira - 2016.pdfDissertação - Júlia Martins Ulhôa Ferreira - 2016.pdfapplication/pdf3148442http://repositorio.bc.ufg.br/tede/bitstreams/7ef536fb-8a22-4021-a555-b69af94627c7/downloadfc17d72cc71fdebb2a4ec57487e7cd21MD55tede/60492016-08-31 10:05:08.62http://creativecommons.org/licenses/by/4.0/Acesso Abertoopen.accessoai:repositorio.bc.ufg.br:tede/6049http://repositorio.bc.ufg.br/tedeRepositório InstitucionalPUBhttp://repositorio.bc.ufg.br/oai/requesttasesdissertacoes.bc@ufg.bropendoar:2016-08-31T13:05:08Repositório Institucional da UFG - Universidade Federal de Goiás (UFG)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
dc.title.por.fl_str_mv Biotransformação da diacereína por fungos e avaliação do potencial citotóxico do seu principal metabólito humano
dc.title.alternative.eng.fl_str_mv Biotransformation of diacerein by fungi and evaluation of the cytotoxic potential of its main human metabolite
title Biotransformação da diacereína por fungos e avaliação do potencial citotóxico do seu principal metabólito humano
spellingShingle Biotransformação da diacereína por fungos e avaliação do potencial citotóxico do seu principal metabólito humano
Ferreira, Júlia Martins Ulhôa
Biotransformação
Diacereína
Aspergillus ochraceus
Glicosilação
Cunninghamella echinulata
Citotoxicidade
Biotransformation
Diacerein
glycosylation
Cytotoxicity
CIENCIAS BIOLOGICAS::FARMACOLOGIA
title_short Biotransformação da diacereína por fungos e avaliação do potencial citotóxico do seu principal metabólito humano
title_full Biotransformação da diacereína por fungos e avaliação do potencial citotóxico do seu principal metabólito humano
title_fullStr Biotransformação da diacereína por fungos e avaliação do potencial citotóxico do seu principal metabólito humano
title_full_unstemmed Biotransformação da diacereína por fungos e avaliação do potencial citotóxico do seu principal metabólito humano
title_sort Biotransformação da diacereína por fungos e avaliação do potencial citotóxico do seu principal metabólito humano
author Ferreira, Júlia Martins Ulhôa
author_facet Ferreira, Júlia Martins Ulhôa
author_role author
dc.contributor.advisor1.fl_str_mv Oliveira, Valéria de
dc.contributor.advisor1Lattes.fl_str_mv http://lattes.cnpq.br/6300240031300604
dc.contributor.referee1.fl_str_mv Oliveira, Valéria de
dc.contributor.referee2.fl_str_mv Paula, José Realino de
dc.contributor.referee3.fl_str_mv Kato, Lucília
dc.contributor.referee4.fl_str_mv Oliveira, Cecília Maria Alves de
dc.contributor.authorLattes.fl_str_mv http://lattes.cnpq.br/7137345573529858
dc.contributor.author.fl_str_mv Ferreira, Júlia Martins Ulhôa
contributor_str_mv Oliveira, Valéria de
Oliveira, Valéria de
Paula, José Realino de
Kato, Lucília
Oliveira, Cecília Maria Alves de
dc.subject.por.fl_str_mv Biotransformação
Diacereína
Aspergillus ochraceus
Glicosilação
Cunninghamella echinulata
Citotoxicidade
topic Biotransformação
Diacereína
Aspergillus ochraceus
Glicosilação
Cunninghamella echinulata
Citotoxicidade
Biotransformation
Diacerein
glycosylation
Cytotoxicity
CIENCIAS BIOLOGICAS::FARMACOLOGIA
dc.subject.eng.fl_str_mv Biotransformation
Diacerein
glycosylation
Cytotoxicity
dc.subject.cnpq.fl_str_mv CIENCIAS BIOLOGICAS::FARMACOLOGIA
description The study of biotransformation is important in the evaluation of safety and efficacy and for developing of new drug candidates. The "microbial models of mammalian metabolism", in which microbial biotransformation is used for the purpose of predict and obtaining human metabolites, is an alternative method to the use of animals for this study. Several advantages such as lower cost, a greater quantity and variety of derivatives produced, using mild conditions of reaction and decreasing the use of toxic volatile organic solvents are observed. The aim of this study was to produce derivatives of diacerein (1,8-diacetoxy-3-carboxyanthraquinone) by biotransformation using filamentous fungi and to evaluate the cytotoxicity of the main derivatives obtained given the resurgence of interest in this class of compounds. The diacerein is an anthraquinone with a wide range of biological activities, like as anti-osteoarthritis, analgesic, anti-inflammatory, antipyretic, prevention of vascular disease, insulin resistance treatment, anticancer. Analytical methodologies have been developed for monitoring the production of derivatives by thin layer chromatography and high-performance liquid chromatography (HPLC). After screening with seventeen fungal strains, Aspergillus ochraceus ATCC 1009 and Cunninghamella echinulata ATCC 9245 were selected for incubation in semipreparative scale. Of these incubations rhein (the main human metabolite) was obtained, which was characterized using the techniques Nuclear Magnetic Resonance (NMR) 1H e 13C, High Resolution Mass Spectrometry (MS), spectrometry in the UV region and analysed by HPLC. Another derivative was obtained by incubation with Aspergillus ochraceus ATCC 1009 and characterized by MS and analyzed by HPLC being, possibly, glycosylated diacerein. The influence of the addition of cytochrome P450 inhibitor in the production of metabolites was performed and inhibited the production of rhein about 41%, which may indicate the involvement of CYP1A1 and CYP1A2 in the deacetylation reaction. The cytotoxic potential of diacerein and rhein was evaluated by the tetrazolium reduction method (MTT) assay using murine fibroblast cells 3T3 and tumor cell line B16F10 (melanoma). Both the rhein, as diacerein, have demonstrated cytotoxic potential against B16F10 cells.
publishDate 2016
dc.date.accessioned.fl_str_mv 2016-08-31T13:05:08Z
dc.date.issued.fl_str_mv 2016-08-16
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.citation.fl_str_mv FERREIRA, Júlia Martins Ulhôa. Biotransformação da diacereína por fungos e avaliação do potencial citotóxico do seu principal metabólito humano. 2016. 99 f. Dissertação (Mestrado em Ciências Farmacêuticas) - Universidade Federal de Goiás,Goiânia, 2016.
dc.identifier.uri.fl_str_mv http://repositorio.bc.ufg.br/tede/handle/tede/6049
identifier_str_mv FERREIRA, Júlia Martins Ulhôa. Biotransformação da diacereína por fungos e avaliação do potencial citotóxico do seu principal metabólito humano. 2016. 99 f. Dissertação (Mestrado em Ciências Farmacêuticas) - Universidade Federal de Goiás,Goiânia, 2016.
url http://repositorio.bc.ufg.br/tede/handle/tede/6049
dc.language.iso.fl_str_mv por
language por
dc.relation.program.fl_str_mv 824936988196152412
dc.relation.confidence.fl_str_mv 600
600
600
600
dc.relation.department.fl_str_mv 6010281161524209375
dc.relation.cnpq.fl_str_mv 700814650651154363
dc.relation.sponsorship.fl_str_mv -2555911436985713659
dc.rights.driver.fl_str_mv http://creativecommons.org/licenses/by/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Goiás
dc.publisher.program.fl_str_mv Programa de Pós-graduação em Ciências Farmacêuticas (FF)
dc.publisher.initials.fl_str_mv UFG
dc.publisher.country.fl_str_mv Brasil
dc.publisher.department.fl_str_mv Faculdade Farmácia - FF (RG)
publisher.none.fl_str_mv Universidade Federal de Goiás
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFG
instname:Universidade Federal de Goiás (UFG)
instacron:UFG
instname_str Universidade Federal de Goiás (UFG)
instacron_str UFG
institution UFG
reponame_str Repositório Institucional da UFG
collection Repositório Institucional da UFG
bitstream.url.fl_str_mv http://repositorio.bc.ufg.br/tede/bitstreams/7218cdd2-7837-4d3c-9ca7-e81de79ffe2b/download
http://repositorio.bc.ufg.br/tede/bitstreams/2fc390f4-f755-4dba-ae5f-840d63f97c1b/download
http://repositorio.bc.ufg.br/tede/bitstreams/fe4c658b-d969-4808-b229-99e734ffa50f/download
http://repositorio.bc.ufg.br/tede/bitstreams/2367e2be-f2c6-4cc8-99e0-9d62601f476e/download
http://repositorio.bc.ufg.br/tede/bitstreams/7ef536fb-8a22-4021-a555-b69af94627c7/download
bitstream.checksum.fl_str_mv bd3efa91386c1718a7f26a329fdcb468
321f3992dd3875151d8801b773ab32ed
d41d8cd98f00b204e9800998ecf8427e
d41d8cd98f00b204e9800998ecf8427e
fc17d72cc71fdebb2a4ec57487e7cd21
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFG - Universidade Federal de Goiás (UFG)
repository.mail.fl_str_mv tasesdissertacoes.bc@ufg.br
_version_ 1798044324197302272